Exchange: NASDAQ·Updated 07:34 PM EDT
News
all
press releases
SOPH Stock Heads For Best Day In Over 8 Months – What’s Driving Today’s Super Rally?
Sophia Genetics announced a partnership with AstraZeneca to develop two cancer diagnostic tests and also raised its full-year revenue forecast.
Stocktwits
More News
SOPHiA GENETICS Reports Second Quarter 2026 Results
SOPHiA GENETICS Reports Second Quarter 2026 Results SOPHiA GENETICS Reports Second Quarter 2026 Results PR Newswire BOSTON and ROLLE, Switzerland, Aug. 4, 2026 BOSTON andROLLE, Switzerland, Aug. 4, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine...
PR Newswire
SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies
SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies PR Newswire BOSTON and ROLLE, Switzerland, Aug. 4, 2026 BOSTON and ROLLE, Switzerland, Aug...
PR Newswire
Tempus AI Stock Before Q2 Earnings Release: To Buy, Hold or Sell?
TEM heads into Q2 earnings with 21.3% expected revenue growth, strong diagnostics demand and AI deals, but near-term margin pressure remains.
Zacks
SOPHiA GENETICS to Announce Financial Results for Second Quarter 2026 on August 4, 2026
SOPHiA GENETICS to Announce Financial Results for Second Quarter 2026 on August 4, 2026 SOPHiA GENETICS to Announce Financial Results for Second Quarter 2026 on August 4, 2026 PR Newswire BOSTON and ROLLE, Switzerland, July 21, 2026 BOSTON and ROLLE, Switzerland, July 21, 2026 /PRNewswire...
PR Newswire
SOPHiA GENETICS Publishes Results of the 2026 Annual General Meeting
SOPHiA GENETICS Publishes Results of the 2026 Annual General Meeting SOPHiA GENETICS Publishes Results of the 2026 Annual General Meeting PR Newswire ROLLE, Switzerland, June 22, 2026 Shareholders adopt all proposals, co-founder Dr. Jurgi Camblong elected as Executive Chairman of the Board, Ross...
PR Newswire
SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters' Option to Purchase Additional Shares
SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters' Option to Purchase Additional Shares SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters' Option to...
PR Newswire
CarMax, Jabil And 3 Stocks To Watch Heading Into Wednesday
U.S. stock futures trading higher. CarMax, Sophia Genetics, Jabil, La-Z-Boy, and Safe Bulkers in focus. La-Z-Boy shares jump 17.7% after earnings.read more...
Benzinga
SOPHiA GENETICS Announces Pricing of $50 Million Public Offering of Ordinary Shares
SOPHiA GENETICS Announces Pricing of $50 Million Public Offering of Ordinary Shares SOPHiA GENETICS Announces Pricing of $50 Million Public Offering of Ordinary Shares PR Newswire BOSTON and ROLLE, Switzerland, June 16, 2026 BOSTON and ROLLE, Switzerland, June 16, 2026 /PRNewswire/ -- SOPHiA...
PR Newswire
SOPHiA GENETICS Announces Proposed Public Offering of Ordinary Shares
SOPHiA GENETICS Announces Proposed Public Offering of Ordinary Shares SOPHiA GENETICS Announces Proposed Public Offering of Ordinary Shares PR Newswire BOSTON and ROLLE, Switzerland, June 16, 2026 BOSTONand ROLLE,Switzerland, June 16, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global...
PR Newswire

Advertisement|Remove ads.